Patents by Inventor John F. Noble

John F. Noble has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent
    Patent number: 6093797
    Abstract: The present invention discloses novel peptides utilized to treat patients suffering from depression. These novel peptides are modifications of the tripeptide hormone MIF, including modification of amino terminus residues, carboxyl terminus residues and internal residues, including addition and substitution of amino acid residues and modification of the peptide bonds and functional side groups of respective amino acid residues. The tri-, tetra-, penta-, peptides and polypeptides of the present invention may be utilized alone or in combination to treat patients suffering from depression.
    Type: Grant
    Filed: November 4, 1997
    Date of Patent: July 25, 2000
    Assignee: Innapharma, Inc.
    Inventors: Henry B. Abajian, John F. Noble, Joseph J. Hlavka
  • Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
    Patent number: 5767083
    Abstract: The present invention discloses novel peptides utilized to treat patients suffering from depression. These novel peptides are modifications of the tripeptide hormone MIF, including modification of amino terminus residues, carboxyl terminus residues and internal residues, including addition and substitution of amino acid residues and modification of the peptide bonds and functional side groups of respective amino acid residues. The tri-, tetra-, penta-, peptides and polypeptides of the present invention may be utilized alone or in combination to treat patients suffering from depression.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: June 16, 1998
    Assignee: Innapharma, Inc.
    Inventors: Henry B. Abajian, John F. Noble, Joseph J. Hlavka
  • Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
    Patent number: 5589460
    Abstract: The present invention discloses novel peptides utilized to treat patients suffering from depression. These novel peptides are modifications of the tripeptide hormone MIF, including modification of amino terminus residues, carboxyl terminus residues and internal residues, including addition and substitution of amino acid residues and modification of the peptide bonds and functional side groups of respective amino acid residues. The tri-, tetra-, penta-, and polypeptides of the present invention may be utilized alone or in combination to treat patients suffering from depression.
    Type: Grant
    Filed: May 4, 1994
    Date of Patent: December 31, 1996
    Assignee: Innapharma, Inc.
    Inventors: Henry B. Abajian, John F. Noble, Joseph J. Hlavka